Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LEWY BODY DISEASE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 320 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Goedert, M
      Alpha-synuclein and neurodegenerative diseases

      NATURE REVIEWS NEUROSCIENCE
    2. Steinling, M; Defebvre, L; Duhamel, A; Lecouffe, P; Lavenu, I; Pasquier, F; Charpentier, P
      Is there a typical pattern of brain SPECT imaging in Alzheimer's disease?

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    3. Trojanowski, JQ; Lee, VMY
      Parkinson's disease and related neurodegenerative synucleinopathies linkedto progressive accumulations of synuclein aggregates in brain

      PARKINSONISM & RELATED DISORDERS
    4. Halliwell, B
      Role of free radicals in the neurodegenerative diseases - Therapeutic implications for antioxidant treatment

      DRUGS & AGING
    5. Tanji, K; Imaizumi, T; Yoshida, H; Mori, F; Yoshimoto, M; Satoh, K; Wakabayashi, K
      Expression of alpha-synuclein in a human glioma cell line and its up-regulation by interleukin-1 beta

      NEUROREPORT
    6. Tanji, K; Mori, F; Nakajo, S; Imaizumi, T; Yoshida, H; Hirabayashi, T; Yoshimoto, M; Satoh, K; Takahashi, H; Wakabayashi, K
      Expression of beta-synuclein in normal human astrocytes

      NEUROREPORT
    7. Love, S
      Damage to nuclear DNA in Lewy body disease

      NEUROREPORT
    8. Sayre, LM; Smith, MA; Perry, G
      Chemistry and biochemistry of oxidative stress in neurodegenerative disease

      CURRENT MEDICINAL CHEMISTRY
    9. Matsuda, H
      Cerebral blood flow and metabolic abnormalities in Alzheimer's disease

      ANNALS OF NUCLEAR MEDICINE
    10. Hashimoto, M; Rockenstein, E; Mante, M; Mallory, M; Masliah, E
      beta-synuclein inhibits alpha-synuclein aggregation: A possible role as ananti-parkinsonian factor

      NEURON
    11. Hsu, YY; Du, AT; Schuff, N; Weiner, MW
      Magnetic resonance imaging and magnetic resonance spectroscopy in dementias

      JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
    12. Boeve, BF; Silber, MH; Ferman, TJ; Lucas, JA; Parisi, JE
      Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy

      MOVEMENT DISORDERS
    13. Cordato, NJ; Halliday, GM; McCann, H; Davies, L; Williamson, P; Fulham, M; Morris, JGL
      Corticobasal syndrome with tau pathology

      MOVEMENT DISORDERS
    14. Dickson, DW
      Neuropathology of Alzheimer's disease and other dementias

      CLINICS IN GERIATRIC MEDICINE
    15. Knopman, DS
      An overview of common non-Alzheimer dementias

      CLINICS IN GERIATRIC MEDICINE
    16. Husain, AM; Miller, TP; Carwile, ST
      REM sleep behavior disorder: Potential relationship to post-traumatic stress disorder

      JOURNAL OF CLINICAL NEUROPHYSIOLOGY
    17. Volicer, L; McKee, A; Hewitt, S
      Dementia

      NEUROLOGIC CLINICS
    18. Glosser, G
      Neurobehavioral aspects of movement disorders

      NEUROLOGIC CLINICS
    19. Spira, PJ; Sharpe, DM; Halliday, G; Cavanagh, J; Nicholson, GA
      Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation

      ANNALS OF NEUROLOGY
    20. Feldman, H; Kertesz, A
      Diagnosis, classification and natural history of degenerative dementias

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    21. Hishikawa, N; Hashizume, Y; Yoshida, M; Sobue, G
      Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    22. Wirdefeldt, K; Bogdanovic, N; Westerberg, L; Payami, H; Schalling, M; Murdoch, G
      Expression of alpha-synuclein in the human brain: relation to Lewy body disease

      MOLECULAR BRAIN RESEARCH
    23. Shen, XM; Dryhurst, G
      Influence of glutathione on the oxidation chemistry of 5-S-cysteinyldopamine: potentially neuroprotective reactions of relevance to Parkinson's disease

      TETRAHEDRON
    24. Van Heertum, RL; Drocea, C; Ichise, M; Lobotesis, K; Fawwaz, RA
      Single photon emission CT and positron emission tomography in the evaluation of neurologic disease

      RADIOLOGIC CLINICS OF NORTH AMERICA
    25. Ala, TA; Hughes, LF; Kyrouac, GA; Ghobrial, MW; Elble, RJ
      Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    26. Ehrhart, J; Zeevalk, GD
      Hydrogen peroxide removal and glutathione mixed disulfide formation duringmetabolic inhibition in mesencephalic cultures

      JOURNAL OF NEUROCHEMISTRY
    27. Iwata, A; Miura, S; Kanazawa, I; Sawada, M; Nukina, N
      alpha-synuclein forms a complex with transcription factor Elk-1

      JOURNAL OF NEUROCHEMISTRY
    28. Lee, M; Hyun, DH; Halliwell, B; Jenner, P
      Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult

      JOURNAL OF NEUROCHEMISTRY
    29. Perrin, RJ; Woods, WS; Clayton, DF; George, JM
      Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins

      JOURNAL OF BIOLOGICAL CHEMISTRY
    30. Giasson, BI; Murray, IVJ; Trojanowski, JQ; Lee, VMY
      A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly

      JOURNAL OF BIOLOGICAL CHEMISTRY
    31. Nakamura, K; Bindokas, VP; Kowlessur, D; Elas, M; Milstein, S; Marks, JD; Halpern, HJ; Kang, UJ
      Tetrahydrobiopterin scavenges superoxide in dopaminergic neurons

      JOURNAL OF BIOLOGICAL CHEMISTRY
    32. Kakimura, J; Kitamura, Y; Takata, K; Kohno, Y; Nomura, Y; Taniguchi, T
      Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole

      EUROPEAN JOURNAL OF PHARMACOLOGY
    33. Kitamura, Y; Ishida, Y; Takata, K; Kakimura, J; Mizutani, H; Shimohama, S; Akaike, A; Taniguchi, T
      alpha-Synuclein protein is not scavenged in neuronal loss induced by kainic acid or focal ischemia

      BRAIN RESEARCH
    34. Arai, Y; Yamazaki, M; Mori, O; Muramatsu, H; Asano, G; Katayama, Y
      alpha-Synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation

      BRAIN RESEARCH
    35. Le Forestier, N; Maisonobe, T; Piquard, A; Rivaud, S; Crevier-Buchman, L; Salachas, F; Pradat, PF; Lacomblez, L; Meininger, V
      Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature

      BRAIN
    36. Muller, J; Wenning, GK; Verny, M; McKee, A; Chaudhuri, KR; Jellinger, K; Poewe, W; Litvan, I
      Progression of dysarthria and dysphagia in postmortem-confirmed Parkinsonian disorders

      ARCHIVES OF NEUROLOGY
    37. Braak, H; Tredici, KD; Sandmann-Keil, D; Rub, U; Schultz, C
      Nerve cells expressing heat-shock proteins in Parkinson's disease

      ACTA NEUROPATHOLOGICA
    38. Mattila, PM; Roytta, M; Lonnberg, P; Marjamaki, P; Helenius, H; Rinne, JO
      Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment

      ACTA NEUROPATHOLOGICA
    39. Piao, YS; Hayashi, S; Hasegawa, M; Wakabayashi, K; Yamada, M; Yoshimoto, M; Ishikawa, A; Iwatsubo, T; Takahashi, H
      Co-localization of alpha-synuclein and phosphorylated tan in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration

      ACTA NEUROPATHOLOGICA
    40. Cras, P
      Recent developments in Alzheimer's disease

      ACTA CLINICA BELGICA
    41. Hashimoto, M; Rockenstein, E; Takenouchi, T; Mallory, M; Masliah, E
      Mechanisms of alpha-synuclein and NAC fibrillogenesis

      ALZHEIMER'S DISEASE
    42. Querfurth, HW; Allam, GJ; Geffroy, MA; Schiff, HB; Kaplan, RF
      Acetylcholinesterase inhibition in dementia with Lewy bodies: Results of aprospective pilot trial

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    43. Lucking, CB; Brice, A
      Alpha-synuclein and Parkinson's disease

      CELLULAR AND MOLECULAR LIFE SCIENCES
    44. Ferini-Strambi, L; Zucconi, M
      REM sleep behavior disorder

      CLINICAL NEUROPHYSIOLOGY
    45. Fridman, EA; Starkstein, SE
      Treatment of depression in patients with dementia - Epidemiology, pathophysiology and treatment

      CNS DRUGS
    46. Kulisevsky, J
      Role of dopamine in learning and memory - Implications for the treatment of cognitive dysfunction in patients with Parkinson's disease

      DRUGS & AGING
    47. El-Agnaf, OMA; Irvine, GB
      Review: Formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins

      JOURNAL OF STRUCTURAL BIOLOGY
    48. Kim, TD; Paik, SR; Yang, CH; Kim, J
      Structural changes in alpha-synuclein affect its chaperone-like activity in vitro

      PROTEIN SCIENCE
    49. Iwai, A
      Properties of NACP/alpha-synuclein and its role in Alzheimer's disease

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    50. Braak, H; Del Tredici, K; Gai, WP; Braak, E
      Alpha-synuclein is not a requisite component of synaptic boutons in the adult human central nervous system

      JOURNAL OF CHEMICAL NEUROANATOMY
    51. Luxenberg, JS
      Clinical issues in the behavioural and psychological symptoms of dementia

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    52. Kurlan, RE; Richard, IH; Papka, M; Marshall, F
      Movement disorders in Alzheimer's disease: More rigidity of definitions isneeded

      MOVEMENT DISORDERS
    53. Wyper, D; Patterson, J
      The utility of neuroSPECT imaging in the investigation of dementia and parkinsonism

      IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE
    54. Piao, YS; Wakabayashi, K; Hayashi, S; Yoshimoto, M; Takahashi, H
      Aggregation of alpha-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients

      CLINICAL NEUROPATHOLOGY
    55. Fahn, S
      The spectrum of levodopa-induced dyskinesias

      ANNALS OF NEUROLOGY
    56. Solano, SM; Miller, DW; Augood, SJ; Young, AB; Penney, JB
      Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: Genes associated with familial Parkinson's disease

      ANNALS OF NEUROLOGY
    57. Tatlidil, R; New, P; Mayberg, H
      FDG positron emission tomography in diffuse Lewy body disease - A case report

      CLINICAL NUCLEAR MEDICINE
    58. Duda, JE; Lee, VMY; Trojanowski, JQ
      Neuropathology of synuclein aggregates: New insights into mechanisms of neurodegenerative diseases

      JOURNAL OF NEUROSCIENCE RESEARCH
    59. Braak, H; Braak, E
      Pathoanatomy of Parkinson's disease

      JOURNAL OF NEUROLOGY
    60. Foley, P; Riederer, P
      Influence of neurotoxins and oxidative stress on the onset and progressionof Parkinson's disease

      JOURNAL OF NEUROLOGY
    61. Kanda, S; Bishop, JF; Eglitis, MA; Yang, Y; Mouradian, MM
      Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation

      NEUROSCIENCE
    62. Jellinger, KA; Stadelmann, C
      Mechanisms of cell death in neurodegenerative disorders

      JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    63. Nestor, P; Hodges, J
      Non-Alzheimer dementias

      SEMINARS IN NEUROLOGY
    64. Caselli, RJ
      Visual syndromes as the presenting feature of degenerative brain disease

      SEMINARS IN NEUROLOGY
    65. Kahle, PJ; Neumann, M; Ozmen, L; Muller, V; Jacobsen, H; Schindzielorz, A; Okochi, M; Leimer, U; van der Putten, H; Probst, A; Kremmer, E; Kretzschmar, HA; Haass, C
      Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain

      JOURNAL OF NEUROSCIENCE
    66. van der Putten, H; Wiederhold, KH; Probst, A; Barbieri, S; Mistl, C; Danner, S; Kauffmann, S; Hofele, K; Spooren, WPJM; Ruegg, MA; Lin, S; Caroni, P; Sommer, B; Tolnay, M; Bilbe, G
      Neuropathology in mice expressing human alpha-synuclein

      JOURNAL OF NEUROSCIENCE
    67. Duyckaerts, C; Takahashi, J; Hogenhuis, J; Hauw, JJ
      Non-Alzheimer degenerative dementias

      ANNALES DE PATHOLOGIE
    68. Reid, RT; Sabbagh, MN; Corey-Bloom, J; Tiraboschi, P; Thal, LJ
      Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer's disease

      NEUROBIOLOGY OF AGING
    69. Hanyu, H; Asano, T; Iwamoto, T; Takasaki, M; Shindo, H; Abe, K
      Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia

      AMERICAN JOURNAL OF NEURORADIOLOGY
    70. Romero-Ramos, M; Venero, JL; Cano, J; Machado, A
      Low selenium diet induces tyrosine hydroxylase enzyme in nigrostriatal system of the rat

      MOLECULAR BRAIN RESEARCH
    71. Floor, E
      Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease

      CELLULAR AND MOLECULAR BIOLOGY
    72. Andersen, JK
      What causes the build-up of ubiquitin-containing inclusions in Parkinson'sdisease?

      MECHANISMS OF AGEING AND DEVELOPMENT
    73. Vercueil, L
      Clinical diagnostic criteria in Parkinson's disease and parkinsonian syndromes: review of the literature.

      REVUE NEUROLOGIQUE
    74. Tiraboschi, P; Hansen, LA; Alford, M; Sabbagh, MN; Schoos, B; Masliah, E; Thal, LJ; Corey-Bloom, J
      Cholinergic dysfunction in diseases with Lewy bodies

      NEUROLOGY
    75. Braak, H; Rub, U; Braak, E
      Neuroanatomy of Parkinson's disease. Changes in the neuronal cytoskeleton in only few of the susceptible cell types leads to progressive destruction of affected regions of the limbic and motor systems

      NERVENARZT
    76. Seno, H; Kobayashi, S; Inagaki, T; Yamamori, C; Miyaoka, T; Horiguchi, J; Wada, M; Harada, T
      Parkinson's disease associated with argyrophilic grains clinically resembling progressive supranuclear palsy: an autopsy case

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    77. Saito, Y; Kawai, M; Inoue, K; Sasaki, R; Arai, H; Nanba, E; Kuzuhara, S; Ihara, Y; Kanazawa, I; Murayama, S
      Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    78. Marui, W; Iseki, E; Ueda, K; Kosaka, K
      Occurrence of human alpha-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer's disease

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    79. Yamazaki, M; Arai, Y; Baba, M; Iwatsubo, T; Mori, O; Katayama, Y; Oyanagi, K
      alpha-synuclein inclusions in amygdala in the brains of patients with the Parkinsonism-dementia complex of Guam

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    80. Mukaetova-Ladinska, EB; Hurt, J; Jakes, R; Xuereb, J; Honer, WG; Wischik, CM
      alpha-synuclein inclusions in Alzheimer and Lewy body diseases

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    81. Nakamura, K; Wright, DA; Wiatr, T; Kowlessur, D; Milstien, S; Lei, XG; Kang, UJ
      Preferential resistance of dopaminergic neurons to the toxicity of glutathione depletion is independent of cellular glutathione peroxidase and is mediated by tetrahydrobiopterin

      JOURNAL OF NEUROCHEMISTRY
    82. Jo, EJ; McLaurin, J; Yip, CM; St George-Hyslop, P; Fraser, PE
      alpha-synuclein membrane interactions and lipid specificity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    83. Biere, AL; Wood, SJ; Wypych, J; Steavenson, S; Jiang, YJ; Anafi, D; Jacobsen, FW; Jarosinski, MA; Wu, GM; Louis, JC; Martin, F; Narhi, LO; Citron, M
      Parkinson's disease-associated alpha-sylnuclein is more fibrillogenic thanbeta- and gamma-synuclein and cannot cross-seed its homologs

      JOURNAL OF BIOLOGICAL CHEMISTRY
    84. Souza, JM; Giasson, BI; Chen, QP; Lee, VMY; Ischiropoulos, H
      Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers - Implication of nitrative and oxidative stress in the pathogenesis ofneurodegenerative synucleinopathies

      JOURNAL OF BIOLOGICAL CHEMISTRY
    85. Okochi, M; Walter, J; Koyama, A; Nakajo, S; Baba, M; Iwatsubo, T; Meijer, L; Kahle, PJ; Haass, C
      Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein

      JOURNAL OF BIOLOGICAL CHEMISTRY
    86. Johnson, WG
      Late-onset neurodegenerative diseases - the role of protein insolubility

      JOURNAL OF ANATOMY
    87. Walker, MP; Ayre, GA; Cummings, JL; Wesnes, K; McKeith, IG; O'Brien, JT; Ballard, CG
      The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale - Two methods to assess fluctuating confusion in dementia

      BRITISH JOURNAL OF PSYCHIATRY
    88. Clarke, NA; Williams, AJ; Kopelman, MD
      Rapid eye movement sleep behaviour disorder, depression and cognitive impairment - Case study

      BRITISH JOURNAL OF PSYCHIATRY
    89. Nakamura, K; Won, L; Heller, A; Kang, UJ
      Preferential resistance of dopaminergic neurons to glutathione depletion in a reconstituted nigrostriatal system

      BRAIN RESEARCH
    90. Zhou, WB; Hurlbert, MS; Schaack, J; Prasad, KN; Freed, CR
      Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells

      BRAIN RESEARCH
    91. Takahashi, M; Iseki, E; Kosaka, K
      Cyclin-dependent kinase 5 (Cdk5) associated with Lewy bodies in diffuse Lewy body disease

      BRAIN RESEARCH
    92. Yang, FS; Ueda, K; Chen, PP; Ashe, KH; Cole, GM
      Plaque-associated alpha-synuclein (NACP) pathology in aged transgenic miceexpressing amyloid precursor protein

      BRAIN RESEARCH
    93. Henderson, JM; Carpenter, K; Cartwright, H; Halliday, GM
      Loss of thalamic intralaminar nuclei in progressive supranuclear palsy andParkinson's disease: clinical and therapeutic implications

      BRAIN
    94. Olson, EJ; Boeve, BF; Silber, MH
      Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases

      BRAIN
    95. Conway, KA; Harper, JD; Lansbury, PT
      Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

      BIOCHEMISTRY
    96. Farber, NB; Rubin, EH; Newcomer, JW; Kinscherf, DA; Miller, JP; Morris, JC; Olney, JW; McKeel, DW
      Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis

      ARCHIVES OF GENERAL PSYCHIATRY
    97. Duda, JE; Giasson, BI; Chen, QP; Gur, TL; Hurtig, HI; Stern, MB; Gollomp, SM; Ischiropoulos, H; Lee, VMY; Trojanowski, JQ
      Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies

      AMERICAN JOURNAL OF PATHOLOGY
    98. Hsu, LJ; Sagara, Y; Arroyo, A; Rockenstein, E; Sisk, A; Mallory, M; Wong, J; Takenouchi, T; Hashimoto, M; Masliah, E
      alpha-synuclein promotes mitochondrial deficit and oxidative stress

      AMERICAN JOURNAL OF PATHOLOGY
    99. Gwinn-Hardy, K; Mehta, ND; Farrer, M; Maraganore, D; Muenter, M; Yen, SH; Hardy, J; Dickson, DW
      Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p

      ACTA NEUROPATHOLOGICA
    100. Wakabayashi, K; Hayashi, S; Yoshimoto, M; Kudo, H; Takahashi, H
      NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains

      ACTA NEUROPATHOLOGICA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 21:37:02